SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006668
Filing Date
2015-08-07
Accepted
2015-08-07 16:11:35
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20150630.htm 10-Q 1648719
2 EX-31.1 dvax-ex311_8.htm EX-31.1 18032
3 EX-31.2 dvax-ex312_9.htm EX-31.2 18002
4 EX-32.1 dvax-ex321_6.htm EX-32.1 6236
5 EX-32.2 dvax-ex322_7.htm EX-32.2 6142
  Complete submission text file 0001564590-15-006668.txt   6407797

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20150630.xml EX-101.INS 1409792
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20150630.xsd EX-101.SCH 39321
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20150630_cal.xml EX-101.CAL 50441
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20150630_def.xml EX-101.DEF 181802
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20150630_lab.xml EX-101.LAB 364920
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20150630_pre.xml EX-101.PRE 286225
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 151037591
SIC: 2834 Pharmaceutical Preparations